COGT EPS Estimates
Cogent Biosciences, Inc.
$29.26
+$1.11(+3.93%)
32
Overall
40
Value
18
Tech
39
Quality
Market Cap
$4.88B
Volume
1.10M
52W Range
$13.78 - $43.73
Target Price
$55.82
COGT EPS estimates: the consensus estimate for Cogent Biosciences, Inc.'s current fiscal year is -$2.23 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
COGT EPS Estimates
- EPS estimate, current quarter
- $-0.57
- EPS estimate, next quarter
- $-0.59
- EPS estimate, current year
- $-2.23
- EPS estimate, next year
- $-1.27
- EPS growth, 3-year
- +3.32%
| Fiscal year | EPS |
|---|---|
| 2025 | $-2.16 |
| 2024 | $-1.94 |
| 2023 | $-2.42 |
| 2022 | $-2.39 |
| 2021 | $-1.87 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | COGT | $29.26 | +3.9% | 1.10M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cogent Biosciences, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW